In their recent Review of chronic myeloid leukamia (CML) stem cell biology (Savona, M. & Talpaz, M. Getting to the stem of chronic myeloid leukemia. Nature Rev.
1
, Savona and Talpaz focus their attention exclusively on deregulated self-renewal mechanisms in Philadelphia chromosome (Ph) + hematopoietic stem cells (HSCs) in chronicphase CML and on the role of β-catenin abnormalities in granulocyte-macrophage progenitors in myeloid blast crisis. However, a review of genomic abnormalities in lymphoid blast crisis provides insights into alternative mechanisms of progenitor self-renewal in BCR-ABL-driven diseases. Deletion of the CDKN2A locus (encoding the INK4A and ARF tumour suppressor genes) frequently occurs in the progression of CML from chronic-phase to lymphoid, but not myeloid, blast crisis 2 , and a recent genome-wide analysis 3 (published concurrently with this CML review) has reinforced the conclusions of earlier studies. INK4A and ARF share common second and third exons, are translated in alternate reading frames, and exhibit no sequence similarity 4 . Whereas p16
INK4A is a bona fide cyclin-dependent kinase inhibitor, p14 ARF (p19 Arf in mice) is not, but instead regulates p53 tumour suppressor function through its interaction with MDM2 (Ref.
5). BCR-ABL induces p19
Arf in vivo to oppose tumour development, but the combination of BCR-ABL expression and Arf inactivation is sufficient to generate leukaemia-initiating cells in a murine model of Ph + acute lymphocytic leukaemia 6 . Therefore, in BCR-ABL-driven lymphoid leukaemias -specifically, CML lymphoid blast crisis and Ph + acute lymphocytic leukaemia -deletion of INK4A and ARF in committed Ph + lymphoid blasts is expected to simultaneously disrupt both the RB and p53 tumour suppressor networks, thereby facilitating leukaemiainitiating cell self-renewal and enhancing targeted therapeutic resistance in vivo.
